The recent developments in the field of epigenetics have changed the way the covalent modifications were perceived from mere chemical tags to important biological recruiting platforms as well as decisive factors in the process of transcriptional regulation and gene expression. Over the years, the parallel investigations in the area of epigenetics and disease have also shown the significance of the epigenetic modifications as important regulatory nodes that exhibit dysfunction in disease states. In the present scenario where epigenetic therapy is also being considered at par with the conventional therapeutic strategies, this article reviews the role of histone acetylation as an epigenetic mark involved in different biological processes associated with normal as well as abnormal gene expression states, modulation of this acetylation by small molecules and warrants the possibility of acetylation as a therapeutic target.
CITATION STYLE
Selvi, B. R., Chatterjee, S., Modak, R., Eswaramoorthy, M., & Kundu, T. K. (2013). Histone acetylation as a therapeutic target. Subcellular Biochemistry, 61, 567–596. https://doi.org/10.1007/978-94-007-4525-4_25
Mendeley helps you to discover research relevant for your work.